Prison diabetes classes tested in paris jail
NCT ID NCT02159417
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether it is possible to run diabetes education workshops for inmates at Paris' La Santé prison. 22 men with type 1 or type 2 diabetes took part in group classes covering diet, foot care, and medication. The main goal was simply to see if prisoners would attend at least two sessions, not to measure blood sugar changes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- therapeutic education (diabetes self-management workshops)
- What this could lead to
- If successful, this could show that structured diabetes education is possible in prison settings, potentially improving care for incarcerated patients.
- What could go wrong
- This is a very small feasibility study (22 participants) at a single prison, so results may not apply elsewhere. It does not test health outcomes directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital COCHIN
Paris, 75014, France
-
Maison d'Arrêt Paris La Santé (MAPLS)
Paris, 75014, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Blood test could predict who faces rapid kidney decline in diabetes
- Can an app and cash rewards tame type 1 diabetes in young adults?
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a single pill tackle both fatty liver and diabetes?